Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroPort NaviBot is an orthopedic surgical robotics company within the MicroPort/Shanghai MicroPort MedBot group focused on robot-assisted joint replacement. Its core products include the Honghu/SkyWalker orthopedic surgical robot and knee replacement planning software, which support total knee and total hip arthroplasty workflows. The company has obtained multiple regulatory clearances and approvals across China, the United States, the European Union, Brazil, Australia, and Japan for its robotic orthopedic platform. NaviBot combines self-developed robotic arms, navigation, and preoperative planning software to improve precision and efficiency in orthopedic surgery. It operates as a subsidiary/associated company of Shanghai MicroPort MedBot and collaborates closely with MicroPort Orthopedics for implant-system integration and commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroPort NaviBot.